CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma
Clinical trial NCT04217317 · TERMINATED
Trial details
- NCT number
- NCT04217317
- Sponsor
- Wake Forest University Health Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2023-04-21
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.